FMP
Cellectar Biosciences, Inc.
CLRB
NASDAQ
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
0.29 USD
-0.0088 (-3.03%)
Earnings
Dividends
We are unable to load the chart at this time.
Splits
From:
To:
Date
Revenue
Earnings
Estimated Earnings
Surprise
2025-03-13
0
-0.01
-0.38
-97.37%
2024-10-29
0
-0.51
-0.37
37.84%
2024-08-13
0
-0.73
-0.23
217.39%
2024-05-14
0
-0.4
-0.5
-20.00%
2024-03-27
330.37k
-0.66
-0.59
11.86%
2023-11-13
0
-0.82
-0.44
86.36%
2023-08-14
0
-0.73
-0.69
5.80%
2023-05-04
0
-0.76
-0.75
1.33%
2023-03-09
0
-0.55
-0.83
-33.73%
2022-11-03
0
-1.28
-1.21
5.79%
2022-08-05
0
-1.22
-1.08
12.96%
2022-05-10
0
-1
-1.1
-9.09%
2022-03-21
0
-1
-1
0.00%
2021-11-08
0
-1
-1.1
-9.09%
2021-08-09
0
-1.1
-1.1
0.00%
2021-05-10
0
-1.3
-0.9
44.44%
2021-03-02
0
-0.7
-1.5
-53.33%
2020-11-09
0
-1.5
-1.5
0.00%
2020-08-10
0
-2.6
-3
-13.33%
2020-05-07
0
-4.2
-3.4
23.53%
2020-03-09
0
-3.3
-3.6
-8.33%
2019-11-12
0
-4.2
-3.8
10.53%
2019-08-12
0
-4.6
-6
-23.33%
2019-05-06
0
-7.6
-5
52.00%
2019-02-26
0
-6.2
-10
-38.00%
2018-11-13
0
-16.5
-8.3
98.80%
2018-08-10
0
-16.9
-21
-19.52%
2018-05-11
0
-21
-20
5.00%
2018-03-21
0
-3.4k
-23
14682.61%
2017-11-09
0
-26
-25
4.00%
2017-08-14
0
-23
-24
-4.17%
2017-05-11
0
-24
-23
4.35%
2017-03-15
0
-35
-23
52.17%
2016-11-10
0
-43
-20
115.00%
2016-08-11
0
-49
-40
22.50%
2016-05-12
0
91
0
-
2016-03-11
0
110.82
0
-
2015-11-12
0
-250
0
-
2015-08-12
0
-300
0
-
2015-05-21
0
-300
0
-
2015-03-24
0
-220
0
-
2014-11-11
0
-100
0
-
2014-08-20
0
-660
0
-
2014-05-14
0
-1k
0
-
2014-03-25
0
-1k
-800
25.00%
2014-03-19
0
-1.38k
0
-
2013-08-12
0
-719.58
0
-
2013-05-15
0
-1.35k
0
-
2013-03-28
0
-100
-100
0.00%
2012-11-06
0
-120
-100
20.00%
2012-08-09
0
-1.16k
0
-
2012-08-09
0
-120
-120
0.00%
2012-03-09
-8.33k
-1.06k
0
-
2012-03-09
0
-120
-100
20.00%
2011-08-12
0
-2.02k
0
-
2011-05-13
8.33k
-6.82k
0
-
2011-04-14
8.33k
-4.01k
0
-
2010-11-19
8.33k
-34.04k
0
-
2010-08-13
8.33k
-49.35k
0
-
2010-05-17
8.33k
-6.12k
-15.3k
-60.00%
